The Anti-ß2-GP-I is a quantitative immunoassay for the determination of IgG and / or IgM antibodies against β2-glycoprotein I (β2-GP I) in human serum. The Anti-ß2-GP-I is intended as an aid in the diagnosis of anti-phospholipid antibody syndrome (APAS) in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
4041 – Anti-ß2 GP-I
Autoimmunity, Diagnostics, ELISA
4041 – Anti-ß2 GP-I
Enzyme immunoassay for the determination of IgG and / or IgM antibodies against β2-glycoprotein I (β2-GP I) in human serum
Available Downloads:
| Indication | Anti-phospholipid antibody syndrome (APAS) |
|---|---|
| Format | Microtiter plate coated with β2-glycoprotein I |
| Total incubation time | 105 min. |
| No. of determinations | 96 (89 x 1) + 5 x Calibrators + 2 x Controls |
Related products
-
3810 – GliaDea IgG
Enzyme immunoassay for the quantitative determination of IgG antibodies against deamidated gliadin in human serum
-
8065 – CytoBead® ANA
Indirect immunofluorescence assay for the determination of IgG antibodies in human serum against nuclear and cytoplasmic antigens
-
8063 – CytoBead® ANCA
The CytoBead® ANCA is an immunofluorescence assay (IFA) for the qualitative and semi-quantitative determination of IgG antibodies in human serum against neutrophil cytoplasmic antigens (ANCA) and the glomerular basal membrane (GBM). The CytoBead® ANCA is is intended as an aid in the diagnosis of systemic vasculitis as well as autoimmune renal disorders in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.